Looking for a hematologic malignancies meeting that helps you think more clearly about the choices that shape patient care?

This program brings data, experience, and differing viewpoints into open conversation so clinicians can work through the real decisions behind treatment choices. Debates, Q and A, and case discussion create a space where evidence is challenged and clarified, making the takeaways immediately useful in practice.

Explore the comparison below to understand what makes LL&M Great Debates a uniquely valuable forum for clinical decision making.

What You Need to Know About LL&M Great Debates

What-You-Need-to-Know-About-LL&M-Great-Debates

    • What is LL&M Great Debates?

      LL&M Great Debates is a CME-accredited hematology-oncology conference focused on lymphoma, leukemia, and multiple myeloma, where experts debate real-world clinical decisions in areas of uncertainty.

      The program centers on complex clinical scenarios where evidence is evolving or open to interpretation, using case-based discussions to compare different treatment approaches.

    • How is LL&M Great Debates different from other oncology conferences?

      LL&M Great Debates differs from traditional oncology conferences by replacing lectures with structured debates on real clinical decisions where evidence is limited, evolving, or open to interpretation.

      Faculty present opposing strategies using clinical data and case scenarios, while attendees participate through live polling, Q&A, and discussion. This format highlights how different experts interpret the same evidence in lymphoma, leukemia, and multiple myeloma.

    • Is LL&M Great Debates worth attending?

      LL&M Great Debates is designed for oncology professionals who want practical guidance on complex treatment decisions in hematologic malignancies.

      Unlike lecture-based meetings, this conference focuses on how decisions are made in real-world scenarios, helping clinicians understand how to apply clinical trial data, evaluate competing approaches, and manage uncertainty in patient care.

    • What will I gain from attending LL&M Great Debates?

      Attendees gain practical, decision-focused insights for managing complex cases in lymphoma, leukemia, and multiple myeloma, including:

      • How experts approach the same clinical scenario differently
      • Frameworks for treatment decision-making in hematologic malignancies
      • Application of emerging clinical trial data in real-world care
      • Case-based discussions reflecting everyday clinical challenges

       

    • Who should attend LL&M Great Debates?

      This hematology-oncology conference is designed for healthcare professionals who treat patients with hematologic malignancies, including lymphoma, leukemia, and multiple myeloma, such as:

      • Hematologists and medical oncologists
      • Advanced practice providers
      • Fellows and trainees
      • Oncology pharmacists
      • Multidisciplinary care team members

      It is especially valuable for clinicians managing complex or controversial treatment decisions.

    • What topics are covered?

      Topics focus on key clinical decision points in lymphoma, leukemia, and multiple myeloma, including:

      • Treatment sequencing strategies
      • Interpretation of emerging clinical trial data
      • Management of therapy-related toxicities
      • Case-based decision-making
      • Areas of evolving or uncertain standards of care
    • Is LL&M Great Debates CME-accredited?

      Yes. LL&M Great Debates is a CME-accredited hematology-oncology conference where attendees can earn continuing medical education (CME) credits focused on clinical decision-making in lymphoma, leukemia, and multiple myeloma.

      Learn more about our accreditation here.

    • How many CME credits can I earn?

      Attendees can earn continuing medical education (CME) credits based on their participation in the conference. The total number of credits that can be earned is 12.

    • Where is LL&M Great Debates held?

      LL&M Great Debates is a hematology conference held in two U.S. locations in 2026:

      • New York City – June 27–28, 2026 (The Westin New York Grand Central)
      • Dallas, TX – July 25–26, 2026 (The Statler Hotel)
    • Is LL&M Great Debates in-person or virtual?

      LL&M Great Debates is an in-person oncology conference designed to support live discussion, audience participation, networking, and real-time debate.

    • How is the agenda developed?

      The LL&M Great Debates agenda is developed by leading hematology-oncology experts and focuses on high-impact clinical questions in hematologic malignancies where treatment decisions are uncertain or evolving.

      Topics are selected based on emerging clinical trial data, real-world treatment challenges, and gaps in clinical consensus.

      View the full agenda to explore upcoming debates.

    • Who are the faculty at LL&M Great Debates?

      Faculty at LL&M Great Debates include leading hematologists, medical oncologists, and advanced practice providers specializing in lymphoma, leukemia, and multiple myeloma.

      Speakers are selected for both clinical expertise and their ability to analyze and defend different treatment strategies in complex clinical scenarios.

      Explore faculty to learn more about participating experts.

    • Why attend LL&M Great Debates?

      LL&M Great Debates is designed for oncology professionals seeking practical, case-based guidance on complex treatment decisions in lymphoma, leukemia, and multiple myeloma.

      The debate-driven format focuses on real-world scenarios and competing approaches, helping clinicians understand how evidence is applied in everyday oncology practice.

      View the agenda to explore upcoming debates or register for the conference to secure your spot.

Why Attend?

Key Features

LL&M Great Debates

Compared to Other Hematology Meetings

Scope of Curriculum Covers the full spectrum of hematologic malignancies (leukemia, lymphoma, myeloma, and CLL) with expert discussions on frontline and relapsed/refractory settings, sequencing, novel agents, and precision medicine. Typically narrower in scope or disease-specific, with limited cross-category insight.
Learning Format Built on point–counterpoint debate, panel dialogue, and open Q&A that place attendees in the conversation. Evidence is examined in real time to clarify clinical decisions, and attendees cast votes before and after the discussions that reveal how each debate shifts perspectives in the room. Commonly lecture-driven with minimal exchange or audience participation.
Integration with LL&M Congress Anchored within the broader LL&M educational ecosystem, offering continuity across the annual Congress, Winter Symposium, and APP Institute to extend learning beyond this meeting. Most meetings operate independently without year-round connection to related programs.
Community & Continuity A longstanding, interactive community that values open debate and shared experience to refine patient care across the hematology spectrum, with each meeting bringing a balanced mix of returning and new faculty. Many conferences function as isolated updates rather than ongoing collaborative forums.
Back to top